
    
      Study on the tumor immune escape in advanced non-small cell lung cancer patients with EGFR
      and ALK mutant negative by NGS combined with RNAseq. Detecting non-small cell lung cancer
      patient NGS and RNAseq data before first-line chemotherapy, after two cycles chemotherapy and
      after disease progression.
    
  